MasterControl Registrations™ Toolkit for Pharma & Biologics Companies

November 15, 2019
Previous
Compliance with FDA's Good Tissue Practices
Compliance with FDA's Good Tissue Practices

This Q&A breaks down the key requirements of 21 CFR Part 1270 (Human Tissue Intended for Transplantation) a...

Next Flipbook
Common Reasons for FDA 483 Inspectional Observations in Biologics Manufacturing Environments
Common Reasons for FDA 483 Inspectional Observations in Biologics Manufacturing Environments

Learn about the most common 483 observations and audit findings, and avoid warning letters by staying compl...